DE69512912T2 - Oligosid-derivate, verfahren zu ihrer herstellung und ihre verwendung - Google Patents
Oligosid-derivate, verfahren zu ihrer herstellung und ihre verwendungInfo
- Publication number
- DE69512912T2 DE69512912T2 DE69512912T DE69512912T DE69512912T2 DE 69512912 T2 DE69512912 T2 DE 69512912T2 DE 69512912 T DE69512912 T DE 69512912T DE 69512912 T DE69512912 T DE 69512912T DE 69512912 T2 DE69512912 T2 DE 69512912T2
- Authority
- DE
- Germany
- Prior art keywords
- intermediary
- molecule
- functional groups
- production
- oligosides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/044—Pyrrole radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/048—Pyridine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Hematology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9407738A FR2721612B1 (fr) | 1994-06-23 | 1994-06-23 | Nouveaux dérivés d'oligosides, leur procédé de préparation et leurs applications. |
PCT/FR1995/000790 WO1996000229A1 (fr) | 1994-06-23 | 1995-06-15 | Nouveaux derives d'oligosides, leur procede de preparation et leurs applications |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69512912D1 DE69512912D1 (de) | 1999-11-25 |
DE69512912T2 true DE69512912T2 (de) | 2000-05-11 |
Family
ID=9464582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69512912T Expired - Fee Related DE69512912T2 (de) | 1994-06-23 | 1995-06-15 | Oligosid-derivate, verfahren zu ihrer herstellung und ihre verwendung |
Country Status (8)
Country | Link |
---|---|
US (1) | US6251858B1 (de) |
EP (1) | EP0766689B1 (de) |
JP (1) | JP3553075B2 (de) |
AT (1) | ATE185810T1 (de) |
AU (1) | AU705200B2 (de) |
DE (1) | DE69512912T2 (de) |
FR (1) | FR2721612B1 (de) |
WO (1) | WO1996000229A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7001994B2 (en) * | 2001-01-18 | 2006-02-21 | Genzyme Corporation | Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins |
US7723296B2 (en) | 2001-01-18 | 2010-05-25 | Genzyme Corporation | Methods for introducing mannose-6-phosphate and other oligosaccharides onto glycoproteins and its application thereof |
KR100601986B1 (ko) * | 2005-02-02 | 2006-07-18 | 삼성전자주식회사 | 유전자를 혼성화하는 방법 |
CN102978185B (zh) * | 2007-01-18 | 2015-02-11 | 建新公司 | 包含氨基氧基基团的寡糖及其轭合物 |
SI2889043T1 (sl) | 2008-12-16 | 2019-08-30 | Genzyme Corporation | Sintetične vmesne spojine za pripravo konjugatov oligosaharid-protein |
US20240050582A1 (en) * | 2021-03-08 | 2024-02-15 | Universiteit Gent | Conjugates including multiple saccharidic chains on a linear protein and uses in mammals feed |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2277823A1 (fr) * | 1974-07-08 | 1976-02-06 | Santerre Orsan | N-osides de l'acide l pyrrolidone-2 carboxylique-5, derives de ceux-ci et compositions cosmetiques en comportant application |
US4478744A (en) * | 1982-01-25 | 1984-10-23 | Sherwood Medical Company | Method of obtaining antibodies |
DE3624376A1 (de) * | 1986-07-18 | 1988-01-28 | Horst Prof Dr Kunz | Glycosylamine und deren n-alkyliden-derivate |
US5028594A (en) * | 1988-12-27 | 1991-07-02 | Naxcor | Use of photodynamic compositions for cytotoxic effects |
JPH07500820A (ja) * | 1991-09-05 | 1995-01-26 | ユニバーシティ オブ コネティカット | ポリヌクレオチド又はオリゴヌクレオチドの細胞への標的を定めた送達 |
AU4993893A (en) * | 1992-07-31 | 1994-03-03 | Neose Pharmaceuticals, Inc. | Compositions for treating and inhibiting gastric and duodenal ulcers |
-
1994
- 1994-06-23 FR FR9407738A patent/FR2721612B1/fr not_active Expired - Lifetime
-
1995
- 1995-06-15 DE DE69512912T patent/DE69512912T2/de not_active Expired - Fee Related
- 1995-06-15 AT AT95923392T patent/ATE185810T1/de not_active IP Right Cessation
- 1995-06-15 WO PCT/FR1995/000790 patent/WO1996000229A1/fr active IP Right Grant
- 1995-06-15 AU AU27962/95A patent/AU705200B2/en not_active Ceased
- 1995-06-15 EP EP95923392A patent/EP0766689B1/de not_active Expired - Lifetime
- 1995-06-15 JP JP50285696A patent/JP3553075B2/ja not_active Expired - Fee Related
- 1995-06-15 US US08/591,481 patent/US6251858B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0766689B1 (de) | 1999-10-20 |
WO1996000229A1 (fr) | 1996-01-04 |
DE69512912D1 (de) | 1999-11-25 |
AU705200B2 (en) | 1999-05-20 |
FR2721612B1 (fr) | 1996-08-09 |
JP3553075B2 (ja) | 2004-08-11 |
ATE185810T1 (de) | 1999-11-15 |
FR2721612A1 (fr) | 1995-12-29 |
JPH10502068A (ja) | 1998-02-24 |
AU2796295A (en) | 1996-01-19 |
US6251858B1 (en) | 2001-06-26 |
EP0766689A1 (de) | 1997-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69031256D1 (de) | Gebundene Schleifkörper, sowie Verfahren zu deren Herstellung und Verwendung | |
DE69821349D1 (de) | Photoinitiatoren und sauerstoffaufnehmende zusammensetzungen | |
DE69617654T2 (de) | Nitroglycerin enthaltende topische creme auf wasserbasis, verfahren zu deren herstellung und verwendung | |
DE68916207T3 (de) | Diamantbeschichtetes Werkzeug, Substrate dafür und Verfahren zu dessen Herstellung. | |
DE69726593D1 (de) | Benzoheterocyclische distamycinderivate, verfahren zu ihrer herstellung und ihre verwendung als antitumor- und antivirale mittel | |
DE58903791D1 (de) | Peptidderivate, verfahren zu ihrer herstellung und ihre verwendung. | |
DE69021341D1 (de) | Härtungsmittel, verfahren zu seiner herstellung und damit hergestellte härtbare zusammensetzung. | |
DE3685840D1 (de) | 3-cyan-pyridine, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung. | |
ATE185810T1 (de) | Oligosid-derivate, verfahren zu ihrer herstellung und ihre verwendung | |
ATE73758T1 (de) | 2,2-difluorcyclopropylethanderivate, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel. | |
DE59409226D1 (de) | Reaktivfarbstoffe, Verfahren zu deren Herstellung und deren Verwendung | |
ATE123274T1 (de) | Gesinterter verbundschleifkörper, verfahren zu seiner herstellung sowie dessen verwendung. | |
DE69626251D1 (de) | Wasserdispergierbare druckempfindliche klebstoffzusammensetzung, verfahren zu deren herstellung und daraus hergestellte druckempfindliche klebeartikel | |
ATE127460T1 (de) | Im wesentlichen aus bisoxazolanen bestehende oxazolangemische, ein verfahren zu deren herstellung und ihre verwendung als härter für isocyanatgruppen aufweisende kunststoffvorläufer. | |
DE59303465D1 (de) | Verfahren zur Reaktivierung eines bei der Herstellung von 1,1,1,2,3,3,3-Heptafluorpropan (R 227) eingesetzten Aktivkohle-Katalysators | |
DE59702009D1 (de) | Verfahren zur herstellung von 1,4,7,10-tetraazacyclododecan und dessen derivaten | |
DE59409563D1 (de) | Reaktivfarbstoffe, Verfahren zu deren Herstellung und deren Verwendung | |
DE69116819D1 (de) | Aktivkohle, Verfahren zur Herstellung und ihre Verwendung zur Adsorption | |
DE69414348D1 (de) | Fluorenonderivate, verfahren zu ihrer herstellung sowie wiederherstellungs- und schutzmittel für zentrale und periphere nervendegenerationen | |
DE59009179D1 (de) | Reaktivfarbstoffe, Verfahren zu deren Herstellung und deren Verwendung. | |
AU1554592A (en) | Interleukin 6 composition and production thereof | |
DE58907811D1 (de) | Reaktivfarbstoffe, Verfahren zu deren Herstellung und deren Verwendung. | |
DE59402216D1 (de) | Fullerenderivate, Verfahren zur Herstellung und deren Verwendung | |
WO1997025365A3 (de) | Polyfunktionell reaktive polymere stoffe | |
DE59503482D1 (de) | Reaktivfarbstoffe, Verfahren zu deren Herstellung und deren Verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |